80803-153 : Fyarro 5 mg/ml Intravenous Injection, Powder, Lyophilized, for Suspension
NDC: | 80803-153 |
Labeler: | Aadi Bioscience |
Product Type: | Human Prescription Drug |
Drug Name: | Fyarro |
Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Suspension |
Application #: | NDA213312 |
Rev. Date: |
NDC Package Codes:
- 80803-153-50: 1 VIAL, SINGLE‑USE IN 1 CARTON (80803‑153‑50) > 20 ML IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Sirolimus
Dosage Strength:
- 5 mg/mL
Pharmaceutical Classes:
- Decreased Immunologic Activity [PE]
- Kinase Inhibitor [EPC]
- Protein Kinase Inhibitors [MoA]
- mTOR Inhibitor Immunosuppressant [EPC]
- mTOR Inhibitors [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 80801-106Next: 80806-510 >
Related Discussions:
sirolimus and eye sight
How does sirolimus effect your eyesight...
How does sirolimus effect your eyesight...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.